Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
International Breast Cancer Study Group (IBCSG); Castiglione-Gertsch M, O'Neill A, Price KN, Goldhirsch A, Coates AS, Colleoni M, Nasi ML, Bonetti M, Gelber RD. International Breast Cancer Study Group (IBCSG), et al. Among authors: gelber rd. J Natl Cancer Inst. 2003 Dec 17;95(24):1833-46. doi: 10.1093/jnci/djg119. J Natl Cancer Inst. 2003. PMID: 14679153 Clinical Trial.
Models for weighing benefits and toxicities.
Gelber RD, Goldhirsch A. Gelber RD, et al. Cancer Treat Res. 1992;60:189-206. doi: 10.1007/978-1-4615-3496-9_8. Cancer Treat Res. 1992. PMID: 1355986 Review. No abstract available.
Adjuvant treatment for breast cancer: the overview.
Gelber RD, Coates AS, Goldhirsch A. Gelber RD, et al. BMJ. 1992 Apr 4;304(6831):859-60. doi: 10.1136/bmj.304.6831.859. BMJ. 1992. PMID: 1392742 Free PMC article. No abstract available.
Meeting highlights: adjuvant therapy for primary breast cancer.
Glick JH, Gelber RD, Goldhirsch A, Senn HJ. Glick JH, et al. Among authors: gelber rd. J Natl Cancer Inst. 1992 Oct 7;84(19):1479-85. doi: 10.1093/jnci/84.19.1479. J Natl Cancer Inst. 1992. PMID: 1433332 Clinical Trial. No abstract available.
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group).
Spataro V, Price K, Goldhirsch A, Cavalli F, Simoncini E, Castiglione M, Rudenstam CM, Collins J, Lindtner J, Gelber RD. Spataro V, et al. Among authors: gelber rd. Ann Oncol. 1992 Nov;3(9):733-40. doi: 10.1093/oxfordjournals.annonc.a058330. Ann Oncol. 1992. PMID: 1450062 Free article.
460 results